Dhanvantri Biomedical Private Limited
Dhanvantri Biomedical Private Limited is a Private Non-govt company company incorporated in 2019 and based in TZ, India. It was founded by Sruthi. Dhanvantri Biomedical Private Limited operates in Medical & Precision (NIC 33119) with authorized capital of ₹10.00 L and paid-up capital of ₹2.00 L. For 2022-23, the company reported revenue of ₹9.23 L and a net loss of ₹48.0K. The board has 1 active director. RegisterKaro's provisional Compliance Health Score for the company is 67/100 (grade C), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
DHANVANTRI BIOMEDICAL PRIVATE LIMITED is the legal entity of Sahayatha.
Quick facts
Directors
1 activeMCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 27 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 20 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +27d | filed |
| MGT-7 | FY2022-23 | 21 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Dhanvantri Biomedical Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 987323104 | ICICI Bank Ltd(Bank) | ₹13.49 Cr | 27 Jan 2021 | Open |
| 413634809 | Axis Bank Ltd(Bank) | ₹1.89 Cr | 12 Mar 2020 | Satisfied |
| 882425692 | Kotak Mahindra Bank Ltd(Bank) | ₹8.86 Cr | 19 Sep 2021 | Open |
| 948643060 | Axis Bank Ltd(Bank) | ₹8.48 Cr | 27 Jan 2020 | Satisfied |
Charge IDs, lenders & amounts for Dhanvantri Biomedical Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2022-23 | — | ||||
| 2021-22 | — | ||||
| 2020-21 | — | ||||
| 2019-20 | — |
Detailed Financials
4 FYs| Line item | 2022-23 | 2021-22 | 2020-21 | 2019-20 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ||||
| Other income | ||||
| Total income | ||||
| Total expenses | ||||
| Profit before tax | ||||
| Profit / (Loss) after tax | ||||
| Balance sheet | ||||
| Equity / Net worth | ||||
| Borrowings | ||||
| Current liabilities | ||||
| Total liabilities | ||||
| Current assets | ||||
| Cash & equivalents | ||||
| Total assets | ||||
| Employees | — | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2022-23 | +8782.0% | — | — | |
| Profit after Tax2022-23 | — | — | — | |
| Net Worth2022-23 | — | — | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2019-20 | — | — | +0.00% | +0.00% | 1.73 | |||
| 2020-21 | — | — | +0.00% | +0.00% | 7.94 | |||
| 2021-22 | -408.06% | — | — | -18.84% | — | |||
| 2022-23 | -5.20% | +1388.71% | — | -2.17% | — |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 4 | 2,55,66,832 | 64.67% |
| Institutional Investors | 3 | 59,57,140 | 15.07% |
| Public & Others | 30 | 80,12,978 | 20.27% |
Promoter, institutional & public holding for Dhanvantri Biomedical Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
8 peersEvents & timeline
2External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.